Engineering Medicine: Tom Fogarty & Medical Device Start-Ups
More medical device companies are being started around relatively focused product plays attractive to both the public markets and big-company acquirors. The most important coming change in surgery, the coupling of less invasive diagnostics and surgery. A conversation with surgeon and device entrepreneur Tom Fogarty on what’s changed over his 30 years of starting up medical device companies.
by Roger Longman
Few people in the early 1990s thought that medical device start-ups would become a hot investment area anytime soon. The...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Ellipsis said it will use its new funding to expand its AI-powered voice assistant Sage across health systems. Ellipsis is part of the global vocal biomarker market, which is expected to exceed $9bn by the end of 2033, according to a research market report.
After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.
European venture capital firm Sofinnova Partners’ portfolio companies BioCorteX, Bioptimus, Cure51 and Latent Labs will benefit from the investor’s new partnership with tech giant NVIDIA.
Despite near-term cost pressures, Intuitive Surgical is expanding manufacturing and R&D in North America and Europe to meet demand for Ion, X and Xi systems.
Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.